Investors
Supporting all investor profiles to secure best in class leaders
Private Equity
The Private Equity market within health, care, and Life Sciences is mature and highly efficient.
Orthodoxy practice of pulling financial levers and improving operations to maximise value are still in place, however the investors who prioritise talent are proving the difference makers.
CCO work with investors throughout an investment cycle and offer a suite of services ranging from assembling boards through to strategic succession planning. We have placed many of the sector’s highest profile hires and can demonstrate a track record of C-suite appointments that have added considerable value and returns to Private Equity houses portfolio businesses.
Venture Capital (VC)
Venture Capital investment is the mainstay of the majority of development stage biotechnology and medical technology businesses.
Funds may focus on therapeutic area, patient need, scientific and technological platforms, or geography. Regardless of initial logic for investment, the vast majority of early-stage investors who support seed rounds commit to working with their investments into clinical development through to commercialization.
Compass Carter Osborne understand the significance of the VC to management relationships; how the investors support boards and guide executive management, preparing for each inflection point and advising on strategy. Leadership teams of biotechs and medtech companies need to evolve in anticipation of each growth stage. We work with investors and executive leadership to bring the best available talent to a developing company with a careful eye on the balance of finding talent in good time while managing the funding impact of team building. We also have a profound understanding of the leadership challenges of growth through company foundation and discovery research, pre-clinical and clinical development phases and the journey toward commercial success.
Infrastructure Funds
The emergence of Infrastructure Funds investing into health and care is recent and increasing.
Defensive investments into state paid for, high governance environments, are attractive to these Infrastructure Funds, as they look to capitalise on consistent incomes and a focussed customer base.
Compass Carter Osborne has been at the forefront of this trend advising international incoming investors on numerous long-term hires as they look to bed-in investments into their broader more traditional portfolio organisations.
Real Estate Investment Trusts (REITs)
Typically residing in the hospital and senior living asset class, REIT’s increasingly hold influence over leadership change and the construct of broader management hires.
CCO have partnered with both UK and international REIT’s in health and care investments advising on new management teams as well as individuals who conduit between investor and opco management.
Family Offices
Not a new phenomenon but as Private Equity considers its longer terms options, Family Offices have been more prevalent as they look to diversify their principal’s funds.
Healthcare provides long-term macro growth assurances and steady returns. Evidence suggests a hold time slightly longer than traditional Private Equity but slightly less than Infrastructure Funds.
CCO are always adaptable to ownership models when advising on board hires and curate their searches in line with the profile of business we are serving. Our track record reinforces that we are adept at transferring candidates from out of sector environments into varying ownership and differing service provisions.
